Nippon India Pharma Fund Direct G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8352.16
Nippon India Pharma Fund Direct G - Nav Details
Nav Date
: 11-Jul-2025
NAV [Rs.]
: 574.3436
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct G- NAV Chart
Nippon India Pharma Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.91 | 0.5 | 11.79 | 1.11 | 12.18 | 25.58 | 23 | 18.3 |
| Category Avg | -0.33 | 1.69 | 11.84 | 0.11 | 13.86 | 25.49 | 22.58 | 17.13 |
| Category Best | 1.09 | 3.34 | 16.83 | 4.08 | 25.07 | 30.16 | 25.6 | 36.84 |
| Category Worst | -1.83 | 0.25 | 8.59 | -5.39 | 0.62 | 20.81 | 17.31 | -3.08 |
Nippon India Pharma Fund Direct G- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.23 | 6256349 | 1,048.37 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 8.50 | 1070031 | 728.63 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.07 | 2683991 | 520.15 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.62 | 3200000 | 481.88 |
| Equity | Apollo Hospitals | Healthcare Services | 5.48 | 648795 | 469.85 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.18 | 3462170 | 444.30 |
| Equity | Medplus Health | Retailing | 3.83 | 3627277 | 328.08 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.63 | 919164 | 311.42 |
| Equity | Narayana Hrudaya | Healthcare Services | 3.55 | 1401811 | 304.24 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.32 | 2886684 | 284.41 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.27 | 1529352 | 280.42 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.88 | 959323 | 246.93 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.86 | 68677 | 244.97 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.31 | 709112 | 198.28 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.31 | 2000632 | 198.05 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.31 | 2555745 | 197.68 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.25 | 1702630 | 193.21 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 2.11 | 318249 | 180.68 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.05 | 757496 | 175.72 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.04 | 1765838 | 174.90 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.96 | 999649 | 167.87 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.87 | 323678 | 159.86 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.71 | 230272 | 146.71 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.64 | 3953457 | 140.62 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.42 | 213659 | 121.70 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.27 | 785412 | 109.15 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.24 | 3269008 | 106.30 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.21 | 303364 | 103.39 |
| Equity | Fortis Health. | Healthcare Services | 1.02 | 1103889 | 87.70 |
| Equity | Syngene Intl. | Healthcare Services | 0.95 | 1280492 | 81.81 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.71 | 470272 | 60.84 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.68 | 1834924 | 58.27 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.65 | 62568 | 55.73 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.65 | 945264 | 55.33 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.41 | 492727 | 35.19 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.24 | 111738 | 20.55 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.61 | 0 | 52.04 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.33 |
| Net CA & Others | Net CA & Others | -/- | -0.04 | 0 | -6.61 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,17,875.24
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
